Cargando…
Inaugural bone metastases in non-small cell lung cancer: a specific prognostic entity?
BACKGROUND: In non-small cell lung cancer patients (NSCLC), median survival from the time patients develop bone metastasis is classically described being inferior to 6 months. We investigated the subcategory of patients having an inaugural skeletal-related-event revealing NSCLC. The purpose of this...
Autores principales: | Deberne, Mélanie, Ropert, Stanislas, Billemont, Bertrand, Daniel, Catherine, Chapron, Jeanne, Goldwasser, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057924/ https://www.ncbi.nlm.nih.gov/pubmed/24913188 http://dx.doi.org/10.1186/1471-2407-14-416 |
Ejemplares similares
-
Reversible Decrease of Portal Venous Flow in Cirrhotic Patients: A Positive Side Effect of Sorafenib
por: Coriat, Romain, et al.
Publicado: (2011) -
Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma
por: Mir, Olivier, et al.
Publicado: (2012) -
Pharmacokinetics and safety of DTS-108, a human oligopeptide bound to SN-38 with an esterase-sensitive cross-linker in patients with advanced malignancies: a Phase I study
por: Coriat, Romain, et al.
Publicado: (2016) -
Inauguration
Publicado: (1990) -
Inauguration at "Serpukhov"
Publicado: (1972)